CVS CVS HEALTH Corp

NYSE cvshealth.com


$ 79.58 $ 1.20 (1.53 %)    

Tuesday, 14-Oct-2025 13:42:09 EDT
QQQ $ 601.61 $ 6.39 (1.07 %)
DIA $ 464.63 $ 7.62 (1.67 %)
SPY $ 665.01 $ 7.72 (1.17 %)
TLT $ 90.62 $ -0.02 (-0.02 %)
GLD $ 381.93 $ 3.63 (0.96 %)
$ 78.44
$ 78.27
$ 79.57 x 101
$ 79.60 x 29
$ 77.82 - $ 79.71
$ 42.12 - $ 79.68
8,435,993
na
99.49B
$ 0.66
$ 21.96
TBD
na
na ($ 0.03)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-31-2025 06-30-2025 10-Q
2 05-01-2025 03-31-2025 10-Q
3 02-12-2025 12-31-2024 10-K
4 11-06-2024 09-30-2024 10-Q
5 08-07-2024 06-30-2024 10-Q
6 05-01-2024 03-31-2024 10-Q
7 02-07-2024 12-31-2023 10-K
8 11-01-2023 09-30-2023 10-Q
9 08-02-2023 06-30-2023 10-Q
10 05-03-2023 03-31-2023 10-Q
11 02-08-2023 12-31-2022 10-K
12 11-02-2022 09-30-2022 10-Q
13 08-03-2022 06-30-2022 10-Q
14 05-04-2022 03-31-2022 10-Q
15 02-09-2022 12-31-2021 10-K
16 11-03-2021 09-30-2021 10-Q
17 08-04-2021 06-30-2021 10-Q
18 05-04-2021 03-31-2021 10-Q
19 02-16-2021 12-31-2020 10-K
20 11-06-2020 09-30-2020 10-Q
21 08-05-2020 06-30-2020 10-Q
22 05-06-2020 03-31-2020 10-Q
23 02-18-2020 12-31-2019 10-K
24 11-06-2019 09-30-2019 10-Q
25 08-07-2019 06-30-2019 10-Q
26 05-01-2019 03-31-2019 10-Q
27 02-28-2019 12-31-2018 10-K
28 11-06-2018 09-30-2018 10-Q
29 08-08-2018 06-30-2018 10-Q
30 05-02-2018 03-31-2018 10-Q
31 02-14-2018 12-31-2017 10-K
32 11-06-2017 09-30-2017 10-Q
33 08-08-2017 06-30-2017 10-Q
34 05-02-2017 03-31-2017 10-Q
35 02-09-2017 12-31-2016 10-K
36 11-08-2016 09-30-2016 10-Q
37 08-02-2016 06-30-2016 10-Q
38 05-03-2016 03-31-2016 10-Q
39 02-09-2016 12-31-2015 10-K
40 10-30-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 morgan-stanley-maintains-overweight-on-cvs-health-raises-price-target-to-89

Morgan Stanley analyst Erin Wright maintains CVS Health (NYSE:CVS) with a Overweight and raises the price target from $82 to...

 goldman-sachs-initiates-coverage-on-cvs-health-with-buy-rating-announces-price-target-of-91

Goldman Sachs analyst Scott Fidel initiates coverage on CVS Health (NYSE:CVS) with a Buy rating and announces Price Target ...

 stocks-tumble-as-trump-mulls-massive-china-tariffs-whats-moving-markets-friday

The stock market stumbled Friday after President Donald Trump threatened a sweeping increase in tariffs on Chinese imports, sen...

 deal-dispatch-confluent-considers-sale-rothschild-exits-the-economist-cvs-feels-the-pain

Confluent explores a sale, Rothschild exits The Economist, Helsing buys Blue Ocean, Zimmer expands robotics, and Omnicare files...

 mizuho-maintains-outperform-on-cvs-health-raises-price-target-to-88

Mizuho analyst Ann Hynes maintains CVS Health (NYSE:CVS) with a Outperform and raises the price target from $76 to $88.

 wells-fargo-maintains-overweight-on-cvs-health-raises-price-target-to-103

Wells Fargo analyst Stephen Baxter maintains CVS Health (NYSE:CVS) with a Overweight and raises the price target from $84 to...

 pfizers-trumprx-pact-sends-shockwaves-why-unitedhealth-lilly-and-cvs-cant-look-away

Pfizer's deal with TrumpRx for steep drug discounts could impact UnitedHealth, Eli Lilly, and CVS. Here's how...

 cvs-healths-aetna-announces-2026-medicare-advantage-products-with-benefits-and-programs-reflecting-diverse-needs-of-members

Providing access to affordable care$0 copays on Tier 1 drugs & covered vaccines at in-network pharmacies1,$0 copay for colo...

 aetna-expands-hospital-program-to-cut-readmissions

Aetna, a CVS Health unit, is expanding its Clinical Collaboration program to 10 hospitals to cut readmissions.

 cvs-healths-omnicare-initiates-voluntary-court-supervised-chapter-11-process-to-resolve-issues-related-to-recent-litigation-in-us-district-court-for-southern-district-of-new-york

Company Intends to Use Process to Implement a Standalone Restructuring or Sale StrategyRemains Focused on Delivering Safe and R...

 aetna-a-cvs-health-company-announced-it-will-scale-the-aetna-clinical-collaboration-program-to-ten-hospitals-by-year-end

Aetna Clinical Collaboration Program on-track to implement in ten hospitals by end of 2025Early indicators show high member eng...

 stock-of-the-day-is-cvs-headed-higher

CVS Health Corporation reverses off of support around the $70 level. There is support at this level because it was resistance.

 mark-cuban-exposes-how-wholesalers-force-pharmacies-into-near-exclusive-deals-detailing-pbms-stranglehold-on-drug-pricing

Mark Cuban explains how PBMs & wholesalers force pharmacies into exclusive deals, creating a 'stranglehold' on pres...

 bernstein-maintains-market-perform-on-cvs-health-raises-price-target-to-77

Bernstein analyst Lance Wilkes maintains CVS Health (NYSE:CVS) with a Market Perform and raises the price target from $72 to...

 barclays-maintains-overweight-on-cvs-health-raises-price-target-to-87

Barclays analyst Andrew Mok maintains CVS Health (NYSE:CVS) with a Overweight and raises the price target from $80 to $87.

Core News & Articles

https://www.hhs.gov/press-room/hhs-expands-access-affordable-catastrophic-health-coverage.html

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION